H.C. Wainwright Reiterates Buy Rating on Trevi Therapeutics (TRVI)

Go back to H.C. Wainwright Reiterates Buy Rating on Trevi Therapeutics (TRVI)
(NASDAQ: TRVI) Delayed: 17.73 -0.07 (0.39%)
Previous Close $17.80    52 Week High
Open $17.97    52 Week Low
Day High $18.06    P/E N/A 
Day Low $17.60    EPS
Volume 1,226,983